McCoy, Barbara, Shire, Cambridge, Estados Unidos
-
Vol. 65 (2018): Suplemento 1: XI Congreso ACAAI. Resúmenes de trabajos libres - Inmunología
Local adverse reaction rates decreased over time during treatment with recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin G (fSCIG) in patients with primary immunodeficiency diseases in the fSCIG phase 3 studies
Resumen PDF